Industry-leading aesthetic company unveils loyalty program designed to elevate practice engagement, enhance patient outcomes, and offer premium rewards across AMP's proprietary bio serums and ...
SAN DIEGO, May 23, 2025 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to ...
(RTTNews) - XOMA Royalty Corporation (XOMA), a biotechnology royalty aggregator, has agreed to acquire Generation Bio Co. (GBIO), a clinical-stage company historically focused on T cell-driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback